Board Member Hubertus Erlen, PhD, will replace Giuseppe Vita as chairman when Vita retires in April. Erlen has board responsibility for human resources and management development for pharmaceutical/chemical manufacturing, with regional responsibility for North America
You may also be interested in...
Berlex Biosciences President Dale Stringfellow, PhD, has been promoted to CEO of Berlex Labs.
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011